Gara Jalqabaatti › Myasthenia Gravis › Wisconsin
Qorannoo klinikaalii Myasthenia Gravis Wisconsin keessatti
Qorannoo 7 Myasthenia Gravis f Wisconsin keessatti hirmaatuu jiru.
Magaalota Wisconsin keessatti
Takkalaa qorannoo (Ingiliffa)
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0038 10108, Greenfield
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07463521A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Milwaukee
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06680037Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1035, Greenfield
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT07039916A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- Center for Neurological Disorders, S.C. - Greenfield - Gamma Therapeutic Center, Greenfield
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Wax-2026 · NCT06456580Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Milwaukee
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Gur-2026 · NCT04202341A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- BCN Research, LLC - Gamma Therapeutic Center, Greenfield
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Gur-2026 · NCT06298565Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Brain Inflammation Collaborative, Delafield
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 22-Ama-2026 · NCT04806620Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.